221 related articles for article (PubMed ID: 36731484)
1. Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis.
Willems RPJ; van Dijk K; Vehreschild MJGT; Biehl LM; Ket JCF; Remmelzwaal S; Vandenbroucke-Grauls CMJE
Lancet Infect Dis; 2023 Jun; 23(6):719-731. PubMed ID: 36731484
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of and risk factors for intestinal colonisation by multidrug-resistant Gram-negative bacteria in patients with haematological malignancies: A systematic review and meta-analysis.
Luo H; Chen X; Jiang Z; Yan Q
Int J Antimicrob Agents; 2024 Jan; 63(1):107043. PubMed ID: 38040318
[TBL] [Abstract][Full Text] [Related]
3. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.
Baur D; Gladstone BP; Burkert F; Carrara E; Foschi F; Döbele S; Tacconelli E
Lancet Infect Dis; 2017 Sep; 17(9):990-1001. PubMed ID: 28629876
[TBL] [Abstract][Full Text] [Related]
4. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
Righi E; Mutters NT; Guirao X; Del Toro MD; Eckmann C; Friedrich AW; Giannella M; Kluytmans J; Presterl E; Christaki E; Cross ELA; Visentin A; Sganga G; Tsioutis C; Tacconelli E
Clin Microbiol Infect; 2023 Apr; 29(4):463-479. PubMed ID: 36566836
[TBL] [Abstract][Full Text] [Related]
5. Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study.
Grohs P; Vilfaillot A; Zahar JR; Barbut F; Frange P; Casetta A; Moulin V; Lawrence C; Baune P; Bourgeois C; Bouffier A; Laussucq C; Sienzonit L; Picard S; Podglajen I; Kassis-Chikhani N
J Antimicrob Chemother; 2022 Sep; 77(10):2667-2678. PubMed ID: 36031727
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis.
Flokas ME; Karageorgos SA; Detsis M; Alevizakos M; Mylonakis E
Int J Antimicrob Agents; 2017 May; 49(5):565-572. PubMed ID: 28336313
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Vancomycin resistant enterococci (VRE) in Ethiopia: a systematic review and meta-analysis.
Melese A; Genet C; Andualem T
BMC Infect Dis; 2020 Feb; 20(1):124. PubMed ID: 32046668
[TBL] [Abstract][Full Text] [Related]
8. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
Tacconelli E; Mazzaferri F; de Smet AM; Bragantini D; Eggimann P; Huttner BD; Kuijper EJ; Lucet JC; Mutters NT; Sanguinetti M; Schwaber MJ; Souli M; Torre-Cisneros J; Price JR; Rodríguez-Baño J
Clin Microbiol Infect; 2019 Jul; 25(7):807-817. PubMed ID: 30708122
[TBL] [Abstract][Full Text] [Related]
9. Variation in definitions and isolation procedures for multidrug-resistant Gram-negative bacteria: a survey of the Society for Healthcare Epidemiology of America Research Network.
Drees M; Pineles L; Harris AD; Morgan DJ
Infect Control Hosp Epidemiol; 2014 Apr; 35(4):362-6. PubMed ID: 24602940
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Genomic surveillance of antimicrobial resistant bacterial colonisation and infection in intensive care patients.
Wyres KL; Hawkey J; Mirčeta M; Judd LM; Wick RR; Gorrie CL; Pratt NF; Garlick JS; Watson KM; Pilcher DV; McGloughlin SA; Abbott IJ; Macesic N; Spelman DW; Jenney AWJ; Holt KE
BMC Infect Dis; 2021 Jul; 21(1):683. PubMed ID: 34261450
[TBL] [Abstract][Full Text] [Related]
12. Patient-level interventions to prevent the acquisition of resistant gram-negative bacteria in critically ill patients: a systematic review.
Zaky A; Zeliadt SB; Treggiari MM
Anaesth Intensive Care; 2015 Jan; 43(1):23-33. PubMed ID: 25579286
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal Carriage of Vancomycin-Resistant Enterococci and Carbapenem-Resistant Gram-Negative Bacteria in an Endemic Setting: Prevalence, Risk Factors, and Outcomes.
Vasilakopoulou A; Karakosta P; Vourli S; Tarpatzi A; Varda P; Kostoula M; Antoniadou A; Pournaras S
Front Public Health; 2020; 8():55. PubMed ID: 32257988
[No Abstract] [Full Text] [Related]
14. Double-carbapenem therapy in the treatment of multidrug resistant Gram-negative bacterial infections: a systematic review and meta-analysis.
Li YY; Wang J; Wang R; Cai Y
BMC Infect Dis; 2020 Jun; 20(1):408. PubMed ID: 32527246
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK).
Goldenberg SD; Dodgson AR; Barlow G; Parcell BJ; Jones L; Albur M; Wilson APR; Enoch DA; Marek A; Micallef C; Manissero D; Longshaw C; Lopes S; Gill K
Adv Ther; 2022 Aug; 39(8):3602-3615. PubMed ID: 35701725
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant gram-negative bacteria in patients with COVID-19: An epidemiological and clinical study.
de Souza GHA; de Oliveira AR; Dos Santos Barbosa M; Rossato L; da Silva Barbosa K; Simionatto S
J Infect Public Health; 2023 Aug; 16(8):1184-1192. PubMed ID: 37271099
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
Litwin A; Fedorowicz O; Duszynska W
Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
[No Abstract] [Full Text] [Related]
18. Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes.
Costa Pde O; Atta EH; Silva AR
J Pediatr (Rio J); 2015; 91(5):435-41. PubMed ID: 26057184
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
[TBL] [Abstract][Full Text] [Related]
20. Prevention and Control of Multidrug-Resistant Gram-Negative Bacteria in Adult Intensive Care Units: A Systematic Review and Network Meta-analysis.
Teerawattanapong N; Kengkla K; Dilokthornsakul P; Saokaew S; Apisarnthanarak A; Chaiyakunapruk N
Clin Infect Dis; 2017 May; 64(suppl_2):S51-S60. PubMed ID: 28475791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
